Factors associated with non-intervention of antifibrotic agents in IPF patients
Antifibrotic treatment interventions varied by facility in cases with good PS. Patients with milder symptoms are not being treated early in general hospitals and more collaboration between general hospitals and specialized facilities is necessary.
Authors
- Kosei Yonezawa
- Ryo Suetake
- Tomoyuki Kakugawa (ORCID: https://orcid.org/0000-0003-1339-1031)
- Maki Asami‐Noyama (ORCID: https://orcid.org/0000-0001-5218-6132)
- Keiji Oishi (ORCID: https://orcid.org/0000-0003-4230-0450)
- Shuichiro Ohata
- Kazuki Hamada (ORCID: https://orcid.org/0000-0002-5082-1486)
- Yoriyuki Murata (ORCID: https://orcid.org/0000-0001-8652-2579)
- Tsunahiko Hirano (ORCID: https://orcid.org/0000-0002-5475-0806)
- Ayumi Fukatsu
- Nobutaka Edakuni
- Kazuki Matsuda
- Yoshikazu Yamaji (ORCID: https://orcid.org/0000-0002-2847-3702)
- Yukari Hisamoto
- Keita Murakawa
- Kazuto Matsunaga (ORCID: https://orcid.org/0000-0002-0514-3241)
- Yoshiyuki Asai (ORCID: https://orcid.org/0000-0001-5519-4306)
- Takeshi Abé (ORCID: https://orcid.org/0000-0002-7074-4561)
- Michiya Watanabe
Institutions
- Yamaguchi University (JP)
- Yamaguchi University Hospital (JP)
Publication Details
- Journal
- Respiratory Investigation
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1016/j.resinv.2024.09.008
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Boehringer Ingelheim Japan